Search research articles
Contact Us
Filters
Showing results (21-30 of 60) with videos related to
Page
of 6
Sort By:
Metabolism: Clinical and Experimental
|
February 29, 2000
Gliclazide decreases low-density lipoprotein oxidation and monocyte adhesion to the endothelium
G Renier, A C Desfaits, O Serri
Clinical Endocrinology
|
April 1, 1997
Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine
F Z Boushaki, E Rasio, O Serri
The Canadian Journal of Cardiology
|
January 1, 1987
Dopamine negatively modulates its own blood pressure increasing action
O Kuchel, N T Buu, O Serri
Journal of Diabetes and Its Complications
|
September 27, 2000
Effect of gliclazide on monocyte-endothelium interactions in diabetes
G Renier, A C Desfaits, O Serri
Diabetes, Obesity & Metabolism
|
February 28, 2001
Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albumin
A C Desfaits, O Serri, G Renier
Human Pathology
|
November 1, 1988
Mixed growth hormone and prolactin-secreting human pituitary adenomas: a pathologic, immunocytochemical, ultrastructural, and immunoelectron microscopic study
F Robert, G Pelletier, O Serri, et al.
Fertility and Sterility
|
April 1, 1986
Decreased sensitivity to insulin in women with microprolactinomas
O Serri, H Beauregard, E Rasio, et al.
Clinical Endocrinology
|
January 1, 1989
Growth hormone-releasing factor increases serum prolactin concentrations in normal subjects and in patients with pituitary adenomas
O Serri, M Somma, E Rasio, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1996
Lactotroph hyperplasia in an estrogen treated male-to-female transsexual patient
O Serri, D Noiseux, F Robert, et al.
Endocrinology
|
April 1, 1992
Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: evidence for a direct and indirect mechanism of action
O Serri, P Brazeau, Z Kachra, et al.
Page
of 6
Search research articles
Search
Showing results (21-30 of 60) with videos related to
Sort By:
Page
of 6
Metabolism: Clinical and Experimental
|
February 29, 2000
Gliclazide decreases low-density lipoprotein oxidation and monocyte adhesion to the endothelium
G Renier, A C Desfaits, O Serri
Clinical Endocrinology
|
April 1, 1997
Hypothalamic-pituitary-adrenal axis in abdominal obesity: effects of dexfenfluramine
F Z Boushaki, E Rasio, O Serri
The Canadian Journal of Cardiology
|
January 1, 1987
Dopamine negatively modulates its own blood pressure increasing action
O Kuchel, N T Buu, O Serri
Journal of Diabetes and Its Complications
|
September 27, 2000
Effect of gliclazide on monocyte-endothelium interactions in diabetes
G Renier, A C Desfaits, O Serri
Diabetes, Obesity & Metabolism
|
February 28, 2001
Gliclazide reduces the induction of human monocyte adhesion to endothelial cells by glycated albumin
A C Desfaits, O Serri, G Renier
Human Pathology
|
November 1, 1988
Mixed growth hormone and prolactin-secreting human pituitary adenomas: a pathologic, immunocytochemical, ultrastructural, and immunoelectron microscopic study
F Robert, G Pelletier, O Serri, et al.
Fertility and Sterility
|
April 1, 1986
Decreased sensitivity to insulin in women with microprolactinomas
O Serri, H Beauregard, E Rasio, et al.
Clinical Endocrinology
|
January 1, 1989
Growth hormone-releasing factor increases serum prolactin concentrations in normal subjects and in patients with pituitary adenomas
O Serri, M Somma, E Rasio, et al.
The Journal of Clinical Endocrinology and Metabolism
|
September 1, 1996
Lactotroph hyperplasia in an estrogen treated male-to-female transsexual patient
O Serri, D Noiseux, F Robert, et al.
Endocrinology
|
April 1, 1992
Octreotide inhibits insulin-like growth factor-I hepatic gene expression in the hypophysectomized rat: evidence for a direct and indirect mechanism of action
O Serri, P Brazeau, Z Kachra, et al.
Page
of 6